<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurochem Res</journal-id><journal-id journal-id-type="iso-abbrev">Neurochem Res</journal-id><journal-title-group><journal-title>Neurochemical Research</journal-title></journal-title-group><issn pub-type="ppub">0364-3190</issn><issn pub-type="epub">1573-6903</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39601897</article-id><article-id pub-id-type="pmc">PMC11602804</article-id>
<article-id pub-id-type="publisher-id">4293</article-id><article-id pub-id-type="doi">10.1007/s11064-024-04293-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rivera-Maya</surname><given-names>Omar B.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ortiz-Robles</surname><given-names>Christian D.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Palacios-Valladares</surname><given-names>Jos&#x000e9; R.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8284-2217</contrib-id><name><surname>Calder&#x000f3;n-Aranda</surname><given-names>Emma S.</given-names></name><address><email>scalder@cinvestav.mx</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/009eqmr18</institution-id><institution-id institution-id-type="GRID">grid.512574.0</institution-id><institution>Department of Toxicology, </institution><institution>Center for Research and Advanced Studies of the National Polytechnic Institute, </institution></institution-wrap>Mexico City, Mexico </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>50</volume><issue>1</issue><elocation-id>35</elocation-id><history><date date-type="received"><day>19</day><month>8</month><year>2024</year></date><date date-type="rev-recd"><day>13</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The dopamine D1-like receptor is a dopamine (DA) receptor regulating diverse brain functions. Once the dopamine D1-like receptor is activated, it induces activation of the Protein Kinase A (PKA) that phosphorylates the cAMP Response Element-Binding (CREB) transcription factor, which once active elicits the expression of the critical synaptic elements Activity-regulated cytoskeleton-associated (Arc) and the Brain-Derived Neurotrophic Factor (BDNF). The temporality and subcellular localization of proteins impact brain function. However, there is no information about the temporality of CREB activation and Arc and BDNF levels induced through dopamine D1-like receptor activation. In this study, we aimed to assess the specific effect of dopamine D1-like receptor activation on the temporality of CREB-phosphorylation (p-CREB<sup>S133</sup>) and the spatiotemporal induction of Arc and BDNF. Using SY-SY5Y cells differentiated with Retinoic Acid (RA), the dopamine D1-like receptor activation with a specific agonist transiently increased p-CREB<sup>S133</sup> at 30&#x000a0;min of stimulation. It induced two spikes of Arc protein at 15&#x000a0;min and 6&#x000a0;h, forming clusters near the cell membrane. BDNF secretion temporarily increased, reaching a maximum at 6&#x000a0;h, while secretion was lower at 24&#x000a0;h compared to the unstimulated group. Our results provide new insight into the role of dopamine D1-like receptor activation on CREB activation, Arc, and BDNF increase, showing that these effects occur temporally and for Arc in subcellular specific sites. This study highlights the dopaminergic system as a critical regulator of subcellular events relevant to neuron plasticity. Future research should address the study of the implications for brain function and behavior.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s11064-024-04293-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Dopamine D1-like receptor</kwd><kwd>Arc</kwd><kwd>Brain-derived neurotrophic factor</kwd><kwd>cAMP response element-binding</kwd><kwd>Protein Kinase A</kwd></kwd-group><funding-group><award-group><funding-source><institution>Mexican Council for Science and Technology</institution></funding-source><award-id>Conacyt-A1-S-32913</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Distinct neurotransmitters involve brain functions such as cognition and emotional or behavioral responses. One of these is the dopaminergic system, which through dopamine (DA), operates through five receptors, subdivided into two families: the dopamine D1-like receptors, constituted by Dopamine Receptor D (DRD)1 and DRD5, and the D2-like receptors, constituted by DRD2, DRD3, and DRD4 [<xref ref-type="bibr" rid="CR1">1</xref>]. It has been established, through deletions and pharmacological tools, that the dopamine D1-like receptor actively participates in the development of memory, learning, and attention [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. However, the underlying mechanisms still need to be fully established. The dopamine D1-like receptor activation induces a cascade reaction including the cyclic adenosine monophosphate (cAMP) production and activation of cAMP-dependent Protein Kinase A (PKA), triggering several responses encompassing transcription, translation, and post-translational modifications of different synaptic players [<xref ref-type="bibr" rid="CR4">4</xref>]. PKA activates the cAMP Response Element-Binding (CREB) transcription factor by phosphorylation in Ser<sup>133</sup> (p-CREB<sup>S133</sup>), which is necessary for CREB to bind at the gene promoter region to initiate gene transcription [<xref ref-type="bibr" rid="CR5">5</xref>]. p-CREB<sup>S133</sup> induces transcription of the Immediate Early Genes (IEGs), such as the <italic>Arc</italic> gene, coding for the Activity-regulated cytoskeleton-associated (Arc) protein, and the <italic>BDNF</italic> gene, coding for the Brain-Derived Neurotrophic Factor (BDNF) [<xref ref-type="bibr" rid="CR6">6</xref>]. The Arc protein (Arg3.1) regulates the trafficking of glutamate receptors and participates in actin polymerization dynamics to modify synaptic structures [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. BDNF functions include the regulation of signaling pathways involved in survival and synaptic events [<xref ref-type="bibr" rid="CR9">9</xref>]. It has been suggested that the function of these proteins, in addition to the expression and activation, requires a specific spatiotemporal location [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Scarce evidence exists on the specific responses elicited by the dopamine D1-like receptor&#x02019;s activity on temporal activation of CREB and expression of Arc and BDNF. Growing evidence suggests that different abnormalities in brain functions are related to alterations not only in protein levels but also in post-translational events like location, transport, recycling, secretion, endocytosis, or second messengers&#x02019; stability, contributing to the development of neurodegenerative conditions like Lafora&#x02019;s, Alzheimer&#x02019;s, and Parkinson&#x02019;s disease [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par3">Regarding the above, we aimed to assess the specific effect of dopamine D1-like receptor activation on the temporality of p-CREB activation and the spatiotemporal induction of Arc and BDNF in SH-SY5Y cells previously differentiated with Retinoic Acid (RA).</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec3"><title>Culture of SH-SY5Y Cells and Differentiation</title><p id="Par4">The SH-SY5Y neuroblastoma cell line (CRL-2266 from ATCC, Manassas, VA, USA) was used in passages 1 to 15. Cells were cultured in DMEM/F12 medium (GIBCO-BRL, Grand Island, NY, USA) supplemented with 10% Fetal Bovine Serum (FBS) (PAN-Biotech, Aidenbach, GER), 1% sodium pyruvate (Sigma-Aldrich, St Louis, MO, USA), 1% L-glutamine (Sigma-Aldrich, St Louis MO, USA), 1% non-essential amino acids (Sigma-Aldrich, St Louis MO, USA), and 1% penicillin-streptomycin (Sigma-Aldrich, St Louis, MO, USA). Cultures were maintained at 37 &#x000ba;C, a CO<sub>2</sub> atmosphere (5%), and a humid environment. Cell differentiation was performed according to previous studies, with minor modifications [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Briefly, the cells were seeded at 30,000 cells/cm<sup>2</sup> density, stabilized for 24&#x000a0;h, and treated with RA 10 &#x000b5;M (Sigma Aldrich, St Louis, Missouri) dissolved in ethanol with 2% FBS for seven days. The supplemented media was renewed every other day. Cell differentiation was confirmed by the assessment of neurites emerging from the cells. Using a phase contrast microscope (Olympus FSX100), images of differentiated cells in culture were taken, and the neurite length was determined using Image J software (NIH, USA). Additionally, the expression of Synapsin (Syn), a specific neuronal marker, was evaluated by Western blot (see below).</p></sec><sec id="Sec4"><title>Cell Treatments</title><p id="Par5">Once the cell differentiation was confirmed, the cells were stimulated with 10 &#x000b5;M of (&#x000b1;)-SKF-38393 (Sigma-Aldrich, St Louis, MO, USA) (only referred to as SKF-38393 in the text body), a specific agonist of dopamine D1-like receptor for 0.25 (15&#x000a0;min), 0.5 (30&#x000a0;min), 1, 6, and 12&#x000a0;h. Exceptionally, for BDNF determination, the time of SKF-38393 stimulation was extended to 24&#x000a0;h. To determine whether effects on proteins of interest depend specifically on dopamine D1-like receptor activation, 10&#x000b5;M of (R)-(+)-SCH-23390 (Sigma-Aldrich, St Louis, MO, USA) (only referred to as SCH-23390), a specific antagonist of the dopamine D1-like receptor, was added 30&#x000a0;min before starting the stimulation with SKF-38393.</p></sec><sec id="Sec5"><title>Cell Viability Assay</title><p id="Par6">Cell viability was determined through mitochondrial activity by the 3-(4,5-dimethyl-2- thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay (Sigma-Aldrich, St. Louis MO, USA), according to Mosmann (1983) [<xref ref-type="bibr" rid="CR16">16</xref>]. The absorbance of MTT was evaluated at 590&#x000a0;nm, and the viability percentage was calculated and compared to controls.</p></sec><sec id="Sec6"><title>Western Blot Detection of Syn, DRD1, Arc, BDNF and p-CREB<sup>S133</sup></title><p id="Par7">The protein levels of DRD1, Syn, Arc, and BDNF were determined in total protein extracts. After treatment, cells were lysed and processed, as previously reported [<xref ref-type="bibr" rid="CR17">17</xref>]. The protein level p-CREB<sup>S133</sup> was assessed in the nuclear extract: cells were lysed with 0.1% Nonidet P40 in Buffer A and processed, as previously reported [<xref ref-type="bibr" rid="CR18">18</xref>]. The Bradford method was used for protein quantitation. Homogeneous quantities (20&#x02013;40&#x000a0;&#x000b5;g/well) of protein from each experimental condition were loaded and separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Proteins were electro-transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore Corporation, Bedford, MA, USA) in a Hoefer semidry transfer unit (Hoefer Pharmacia Biotech Inc, San Francisco, CA, USA). PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1&#x000a0;h. Membranes were incubated overnight at 4&#x000a0;&#x000b0;C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB<sup>S133</sup> (1:500), &#x003b2;-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). &#x003b2;-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively. Membranes were washed three times with PBS-Tween 1% and incubated with horseradish peroxidase (HRP)-conjugated to anti-goat Ab (1:3000) (Santa Cruz Biotech., Santa Cruz, CA, USA) or HRP-conjugated anti-mouse Ab (1:3000) (Bio-Rad, Hercules CA, USA) for 2&#x000a0;h at room temperature. After washing three times with PBS-Tween, bands were visualized using Western blotting luminol reagents (Bio-Rad, Hercules CA, USA) detecting chemiluminescence signal by the photo-documenter Fusion FX (Vilber, Marne-la-Vall&#x000e9;e, FR). Densitometric analyses were performed using ImageJ software (NIH, USA).</p></sec><sec id="Sec7"><title>Immunofluorescence Assay for Arc and p-CREBS133 Proteins Cell Location</title><p id="Par8">SH-SY5Y cells were seeded at 20,000 cells/cm<sup>2</sup> density and differentiated onto Nunc&#x02122; Lab-tek&#x02122; II chamber slides (Thermo Scientific, Waltham, MA, USA). The staining protocol was according to what had already been reported [<xref ref-type="bibr" rid="CR19">19</xref>]. Cells were stained with mouse anti-Arc or mouse anti-p-CREB<sup>S133</sup> antibodies (Santa Cruz Biotech., Santa Cruz, CA, USA) (both at 1:30). The secondary antibody fluorescein isothiocyanate (FITC)-conjugated anti-mouse-IgG (Thermo Scientific, Waltham, MA, USA, 1:300). The cytoskeleton was stained with 1:250 tetramethyl rhodamine B isothiocyanate (TRITC)-phalloidin (Sigma-Aldrich, St. Louis, MO, USA). Nuclei were detected with 1:500 of 4&#x02032;, 6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, St. Louis, MO, USA). The cells were mounted in Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA), and fluorescent images were captured with a confocal laser microscope (TCS SP8 DM6000, Leica Microsystems).</p></sec><sec id="Sec8"><title>Detection of BDNF Secretion</title><p id="Par9">The BDNF-secreted and intracellular protein levels were determined in cell culture supernatant media using a quantitative antigen capture Enzyme-linked immunosorbent assay (ELISA) against the mature form of BDNF. The ELISA assay was performed according to the manufacturer&#x02019;s instructions for Duo Set Kits (R&#x00026;D Systems, Minneapolis, MN, USA).</p></sec><sec id="Sec9"><title>PKA Activity Assay</title><p id="Par10">The PKA activity was quantified in cell lysate using a PKA Kinase Activity Kit (Enzo Life Sci., Inc., Farmingdale, NY, USA) according to the manufacturer&#x02019;s instructions. After differentiation and treatments, cells were lysed, and the Bradford method was used to quantify the protein concentration. Then, 0.1&#x000a0;&#x000b5;g of whole protein per well was loaded onto the PKA Substrate Microtiter Plate after following the manufacturer&#x000b4;s instructions. Briefly, the PKA in cell lysates was activated by adding ATP to phosphorylate to the specific peptide substrate previously adhered to the plate. A specific antibody was added to phospho-specific substrate detection, and subsequently, a peroxidase-conjugated antibody and the substrate tetramethylbenzidine were used. The reaction was stopped with an acid solution, and the absorbance was read in a spectrophotometer at 450&#x000a0;nm. The formula for calculating the PKA activity was:</p><p id="Par11">
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\eqalign{&#x00026; {\text{Relative Activity Kinase }} = \cr &#x00026; {{{\text{Average absorbance of sample }} - {\text{ Average absorbance of blank}}} \over {{\text{Quantity of crude protein used per assay}}}} \cr} $$\end{document}</tex-math><graphic xlink:href="11064_2024_4293_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p></sec><sec id="Sec10"><title>Statistical Analysis</title><p id="Par12">After determining data normality using the Shapiro-Wilk test, the data were analyzed using the one-way or two-way ANOVA tests followed by the Bonferroni or Tukey <italic>post hoc</italic> test as established in figure legends. The student&#x02019;s t-test was used to compare two groups (the control versus a specific treated condition), as indicated in figure legends. The data are expressed as the mean&#x02009;&#x000b1;&#x02009;SEM of three independent experiments. The p-value&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. Statistical analysis was performed using Graph Pad Prism 5.0 software (Graph Pad Software, Inc., San Diego, CA, USA).</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><sec id="Sec12"><title>Morphological and Molecular Changes in SH-SY5Y Cells Differentiated with RA</title><p id="Par13">The SH-SY5Y human neuroblastoma cells (with a well-known ability to be differentiated to like-neuronal phenotype) were subjected to seven days of differentiation process treatment with RA 10 &#x000b5;M. After, morphological and molecular changes in RA-treated cells were compared with the untreated cells to confirm differentiation. The RA-treated cells show neurite formation (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a), characterized by long processes (like-filopodia structure) arising from the cell soma, showing a significant augment of neurite length compared to the untreated cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). Additionally, the RA-treated cells have a higher expression of Syn, a molecular marker for mature neurons, compared to the untreated cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c). These results confirm the SH-SY5Y cell differentiation to neuronal-like phenotype after treatment with RA.</p><p id="Par14">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Morphologic and molecular changes after seven days of differentiation with RA in SH-SY5Y cells. <bold>a</bold>) representative micrographs showing the emergent neurites (red arrow) of the SH-SY5Y cells treated (right) and untreated (left) with RA; <bold>b</bold>) each bar represents the neurite length mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;4 cells/per micrograph by triplicate) determined in pixels from soma to the end of each process from three independent experiments. <bold>c</bold>) A representative immunoblot of the Syn and &#x003b2;-Actin expression is shown; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of the Syn/Actin ratio from three independent experiments. A Student&#x000b4;s <italic>t</italic>-test was used to determine differences induced by RA treatment; ** <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 indicated statistical difference compared RA treatment to w/o treatment</p></caption><graphic xlink:href="11064_2024_4293_Fig1_HTML" id="d33e371"/></fig>
</p></sec><sec id="Sec13"><title>Effects of RA-induced SH-SY5Y Differentiation on Levels of DRD1, PKA, p-CREB<sup>S133</sup>, Arc, and BDNF</title><p id="Par15">The levels of DRD1 (a member of the dopamine D1-like receptor), p-CREB<sup>S133</sup>, Arc, and BDNF proteins, and the PKA activity were evaluated in RA-treated and untreated cells. No difference in DRD1 protein levels (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a) and PKA activity (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b) was observed between both groups. The p-CREB<sup>S133</sup> and Arc levels increased significantly in RA-treated compared to untreated cells (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c, d). The intracellular BDNF levels in RA-treated cells were lower than in the untreated cells (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>e). However, in the culture&#x02019;s supernatant, a significant increase of BDNF secreted by RA-treated cells compared to baseline levels in untreated cells was observed (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>f). These results confirm that RA-induced SH-SY5Y differentiation triggers the increase of p-CREB<sup>S133</sup>, Arc, and the BDNF secretion, without affecting the DRD1 level nor the PKA activity. Considering this evidence, the subsequent experiments were performed only in RA-treated cells.</p><p id="Par16">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of the RA-induced differentiation on DRD1 level, PKA activity, p-CREB<sup>S133</sup>, Arc, and BDNF intracellular level/secretion in SH-SY5Y cells. In cultures treated or not with RA (10&#x000b5;M) were determined: <bold>a</bold>) The DRD1 level (immunoblot at the bottom); each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of DRD1/&#x003b2;-actin ratio from three independent experiments. <bold>b</bold>) The PKA activity level; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of Relative activity kinase from three independent experiments in duplicates. <bold>c</bold>) The nuclear expression level of p-CREB<sup>S133</sup> (immunoblot at the bottom); each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of p-CREB<sup>S133</sup>/Lamin B ratio from three independent experiments, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 statistical difference compared RA treatment to w/o treatment. <bold>d</bold>) The expression level of Arc (immunoblot at the bottom); each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of Arc/&#x003b2;-actin ratio from three independent experiments, *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared RA treatment to w/o treatment. The BDNF (<bold>e</bold>) intracellular and (<bold>f</bold>) secreted level, each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of BDNF from three independent experiments by duplicate, ** <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and **** <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001 statistical differences compared RA treatment to w/o treatment. Data were analyzed by t-student test</p></caption><graphic xlink:href="11064_2024_4293_Fig2_HTML" id="d33e449"/></fig>
</p></sec><sec id="Sec14"><title>Effects of the Dopamine D1-like Receptor Activation in RA-treated SH-SY5Y Cells on DRD1 Protein Level and PKA Activity</title><p id="Par17">Since the dopamine D1-like receptor activation triggers the cAMP/PKA signaling [<xref ref-type="bibr" rid="CR4">4</xref>], to determine whether the treatment with SKF-38393 activated this DA receptor, the PKA activity level was evaluated after 0.25, 0.5, 1, 6, and 12&#x000a0;h. Treatment with SKF-38393 transiently increased the PKA activity at 0.5&#x000a0;h compared to the non-activated control (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). With this result, it was hypothesized that the DRD1 level changes by its activation with SKF-38393. However, no modification occurred in DRD1 levels after stimulation at all times evaluated (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). The induction of the PKA activity by the agonist of the dopamine D1-like receptor suggests that these receptors are functional in RA-treated SH-SY5Y cells.</p><p id="Par18">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Effects of dopamine D1-like receptor activation on PKA activity and DRD1 level. <bold>a</bold>) the PKA activity was determined at indicated times of stimulation with SKF-38393 (10&#x000b5;M); each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of Relative activity kinase from three independent experiments by duplicated, * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells stimulated with SKF-38393 (0.5&#x000a0;h) to cells w/o stimulation (F&#x02009;=&#x02009;3.071). <bold>b</bold>) A representative immunoblot result of DRD1 and &#x003b2;-Actin is at the bottom; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of DRD1/&#x003b2;-Actin ratio from three independent experiments (F&#x02009;=&#x02009;0.2998). Data were analyzed using a one-way ANOVA and Tukey&#x000b4;s <italic>post hoc</italic> tests</p></caption><graphic xlink:href="11064_2024_4293_Fig3_HTML" id="d33e485"/></fig>
</p></sec><sec id="Sec15"><title>The Dopamine D1-like Receptor Activation Transiently Induces CREB<sup>S133</sup> Phosphorylation, Arc, and BDNF</title><p id="Par19">The RA-treated cells were stimulated with SKF-38393 for 0.25, 0.5, 1, 6, and 12&#x000a0;h to evaluate the effects of activation of dopamine D1-like receptor on the level of p-CREB<sup>S133</sup>, the level and location of Arc, and secretion of BDNF. The BDNF secretion was also evaluated at 24&#x000a0;h. The nuclear p-CREB<sup>S133</sup> level significantly increased at 0.5&#x000a0;h after the dopamine D1-like receptor activation compared to the non-activated control (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). The dopamine D1-like receptor activation induced two spikes of the Arc protein compared to the non-activated control; an early spike was observed at 0.25&#x000a0;h and a late one was observed at 6&#x000a0;h (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). The dopamine D1-like receptor stimulation induced a significant increase in BDNF secretion at 6&#x000a0;h compared to non-activated control (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). In contrast, after 24&#x000a0;h of dopamine D1-like receptor stimulation, the level of BDNF secretion was lower than in the non-activated control. As the BDNF secretion reached the maximum levels at 6&#x000a0;h of dopamine D1-like receptor activation, this time was chosen to be quantified in the subsequent experiments.</p><p id="Par20">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Effects of dopamine D1-like receptor activation on p-CREB <sup>S133</sup>level,Arc level,and BDNF secretion. <bold>a</bold>) A representative immunoblot of p-CREB<sup>S133</sup> and Lamin B is at the bottom of the graphic; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of the p-CREB<sup>S133</sup>/Lamin B ratio from three independent experiments, * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells stimulated with SKF-38393 (10 &#x000b5;M) (0.5&#x000a0;h) to cells w/o stimulation (F&#x02009;=&#x02009;6.517). <bold>b</bold>) A representative immunoblot of the Arc and &#x003b2;-actin level is at the bottom of the graphic. Each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of the Arc/Actin ratio from three independent experiments, * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6&#x000a0;h) to cells non-stimulated (F&#x02009;=&#x02009;4.378). <bold>c</bold>) ELISA determined the BDNF secretion; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of three independent experiments by duplicated, * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells stimulated with SKF-38393 (6 and 24&#x000a0;h) to cells w/o stimulation. Results in <bold>a</bold>) and <bold>b</bold>) were analyzed using a one-way ANOVA test and Dunnet&#x000b4;s <italic>post hoc</italic> tests. Results of <bold>c</bold>) were analyzed using a two-way ANOVA test and Tukey&#x000b4;s <italic>post hoc</italic> test</p></caption><graphic xlink:href="11064_2024_4293_Fig4_HTML" id="d33e557"/></fig>
</p></sec><sec id="Sec16"><title>A Specific Antagonist of Dopamine D1-like Receptors Prevented the Effect Induced by Dopamine D1-like Receptor Activation on CREB, Arc, and BDNF</title><p id="Par21">A selective antagonist of the dopamine D1-like receptor (SCH-23390) was used before stimulating with SKF-38393 to evaluate whether the CREB, Arc, and BDNF inductions depended on dopamine D1-like receptor activation. In the presence of the antagonist SCH-23390, significant inhibition of the SKF-38393-induced nuclear level of p-CREB<sup>S133</sup> (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a), the Arc level (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b), and the BDNF secretion (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>c) was observed without affecting the basal levels of all of them.</p><p id="Par22">
<fig id="Fig5"><label>Fig. 5</label><caption><p>Blocking the dopamine D1-like receptor inhibits the Arc, BDNF, and p-CREB <sup>S133</sup> induction. After the pretreatment with antagonist SCH-23390 (10&#x000b5;M), the cells were stimulated with agonist SKF-38393 (10 &#x000b5;M) at maximum induction time for each parameter. <bold>a</bold>) A representative immunoblot of p-CREB<sup>S133</sup> and Lamin B levels is at the bottom of the graphic; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of p-CREB<sup>S133</sup>/Lamin B ratio from three independent experiments, ** <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 statistical difference compared cells stimulated with SKF-38393 (0.5&#x000a0;h) to cells w/o stimulation, and <sup>&#x00026;&#x00026;</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 cells treated with SCH-23390&#x02009;+&#x02009;SKF-38393 to cells stimulated with SKF-38393. <bold>b</bold>) A representative immunoblot of Arc and &#x003b2;-Actin level is at the bottom of the graphic; each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM of the Arc/&#x003b2;-Actin ratio from three independent experiments, ** <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6&#x000a0;h) to cells w/o stimulation, and <sup>&#x00026;</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells treated with SCH-23390&#x02009;+&#x02009;SKF-38393 (6&#x000a0;h) to cells stimulated with SKF-38393 (6&#x000a0;h) (F&#x02009;=&#x02009;v4.564 for 0.25&#x000a0;min and F&#x02009;=&#x02009;14.98 for 6&#x000a0;h). <bold>c</bold>) The BDNF secretion level determined by ELISA, each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM from three independent experiments by duplicated, * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 statistical difference compared cells stimulated with SKF-38393 to cells w/o stimulation (F&#x02009;=&#x02009;11.52). Data were analyzed using a <italic>t</italic>-test or one-way ANOVA test followed by a Tukey <italic>post hoc</italic> test</p></caption><graphic xlink:href="11064_2024_4293_Fig5_HTML" id="d33e623"/></fig>
</p></sec><sec id="Sec17"><title>The Dopamine D1-like Receptor Activation is Critical for p-CREB<sup>S133</sup> and Arc Location</title><p id="Par23">Dopamine D1-like receptor activation induced a remarkable nuclear location of p-CREB<sup>S133</sup> at 0.5&#x000a0;h, compared to the scarce cytoplasmic and nuclear location of the non-activated control (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a). Notably, the presence of SCH-23390 inhibited the nuclear location of p-CREB<sup>S133</sup> induced by SKF-38393 (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a). These results corroborate that dopamine D1-like receptor activation specifically induces CREB<sup>S133</sup> phosphorylation at the nuclear level.</p><p id="Par24">
<fig id="Fig6"><label>Fig. 6</label><caption><p><italic>Effects of dopamine D1-like receptor on p-CREB</italic><sup><italic>S133</italic></sup><italic>and Arc location</italic>. After blocking (or not) the D1-like receptor, the cells were stimulated with SKF-38393 (10 &#x000b5;M) at indicated times. (<bold>a</bold>) After thirty minutes of stimulation, the p-CREB<sup>S133</sup> location was immunodetected with an antibody against phosphorylated CREB in Ser<sup>&#x02212;&#x02009;133</sup> (green); the F-actin was labeled with TRITC-phalloidin (red), and the nucleus was stained by DAPI (blue). For SKF-38,393 (10 &#x000b5;M), the yellow arrowheads indicate the prominent location of p-CREB<sup>S133</sup> concurring in the nucleus visualized by the white circles in the merge column. (<bold>b</bold>) After fifteen minutes or six hours of stimulation, the Arc location was detected by immunofluorescence labeling Arc protein (green); the F-actin was labeled using TRITC-phalloidin (red); the nucleus was stained by DAPI (blue). An area (white dotted square) was magnified. The white arrow/squares point out the clusters of Arc near the cell membrane and lamellipodial F-actin structures without colors overlapping in merge at 0.25&#x000a0;h. In contrast, at 6&#x000a0;h, the white arrowheads point out the yellow dots corresponding to Arc location (green) overlapping with F-actin (red)</p></caption><graphic xlink:href="11064_2024_4293_Fig6_HTML" id="d33e673"/></fig>
</p><p id="Par25">The Arc location was determined at times corresponding to both peaks (0.25 and 6&#x000a0;h). Compared to the non-stimulated control, the dopamine D1-like receptor activation induced Arc location as clusters near the cell membrane. However, only at 6&#x000a0;h Arc colocalizes with regions rich in lamellar F-actin compared to the 0.25&#x000a0;h Arc peak (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>b). As occurred with protein, SCH-23390 inhibited the effects of SKF-38393 on Arc (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>S in Online Resource 1).</p><p id="Par26">Additionally, we recorded the morphological changes in cell morphology induced by dopamine D1-like receptor activation, as well as by the antagonist of the dopamine D1-like receptor (Fig.&#x000a0;2aS in Online Resource 1). The activation of the dopamine D1-like receptor with SKF-38393 did not induce an apparent change in cell morphology or neurite length compared to non-activated control cells. Remarkably, blocking the dopamine D1-like receptor with SCH-23390 antagonist produced a dramatic retraction of neurites compared to the non-activated control and SKF-38393 stimulation groups without affecting the viability cell in all conditions compared to the control group (Fig.&#x000a0;2bS in Online Resource 1).</p></sec><sec id="Sec18" sec-type="discussion"><title>Discussion</title><p id="Par27">The cognitive and executive functions of the brain are orchestrated by distinct neurotransmitters through their receptors, modulating the production and function of synaptic proteins [<xref ref-type="bibr" rid="CR20">20</xref>]. Information about how dopamine D1-like receptor activation regulates the production of some relevant synaptic proteins is scarce, even though the evidence suggests that dopamine D1-like receptor activity is essential to several forms of synaptic plasticity [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]&#x0200b;. The present study was focused on determining the effects of dopamine D1-like receptor activation on CREB, Arc, and BDNF, particularly on CREB activation and BDNF secretion temporality, as well as spatiotemporal induction of Arc.</p></sec><sec id="Sec19"><title>RA-treated SH-SY5Y Cells as a Study Model</title><p id="Par28">Our study used RA-treated SH-SY5Y, which was previously reported as a suitable cell model for in vitro neurobiological studies, and it expresses the functional DA receptors [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. It is known that BDNF is secreted by mature neurons in in vivo physiological conditions [<xref ref-type="bibr" rid="CR23">23</xref>]. The results did not show changes in the DRD1 protein expression in RA-differentiated SH-SY5Y compared to the undifferentiated cells. However, the morphological changes and increasing expression of Syn, p-CREB<sup>S133</sup>, and Arc and BDNF secretion supported previous studies reporting that RA-treated SH-SY5Y cells are a suitable cell model in our study.</p></sec><sec id="Sec20"><title>CREB as a Target of Dopamine D1-like Receptor Activation</title><p id="Par29">As was expected, the maximum CREB activation (0.5&#x000a0;h) concurred with the maximum PKA activity (0.5&#x000a0;h), supporting that the PKA/CREB signaling axis is activated in response to dopamine D1-like receptor activation. Because CREB is the effector molecule in this axis, the changes in its activation over time were studied. CREB is a master regulator of <italic>Arc</italic>, <italic>BDNF</italic>, <italic>c-fos</italic>, <italic>c-jun</italic>, and other <italic>IEG</italic>s involved in cognitive functions [<xref ref-type="bibr" rid="CR24">24</xref>]&#x0200b;&#x0200b;. CREB is activated by PKA among different kinds of kinases [<xref ref-type="bibr" rid="CR25">25</xref>]. In the brain, CREB activity is induced via anionic channel activation, AMPA or NMDA receptors, and the dopamine D1-like receptor [<xref ref-type="bibr" rid="CR6">6</xref>]. Our results indicate that the level of p-CREB<sup>S133</sup> is dependent on dopamine D1-like receptor activation. The augment was <italic>transient</italic>, reaching the maximum level at 0.5&#x000a0;h. It has been suggested that the duration of phosphorylation of CREB depends on the received input and is critical to the subsequent expression of IEGs [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. The <italic>c-fos</italic> gene induced through D1/D5 receptors or via L-type Ca<sup>2+</sup> channels correlated with <italic>sustained</italic> CREB phosphorylation but not with its <italic>transient</italic> phosphorylation [<xref ref-type="bibr" rid="CR28">28</xref>]. However, growth hormone elicits <italic>c-fos</italic> expression associated with <italic>transient</italic> phosphorylation [<xref ref-type="bibr" rid="CR29">29</xref>]. These data suggest that the distinctive effect depends on the input received.</p><p id="Par30">Other pathways related to regulating sustained CREB phosphorylation in SH-SY5Y cells are phosphoinositide hydrolysis and Ca2&#x02009;+&#x02009;mobilization [<xref ref-type="bibr" rid="CR30">30</xref>]. t has been reported that the dopamine D1-like receptor activation by SKF-38393 increased the production of inositol phosphate in brain slices of wild-type mice but not in dopamine D5 receptor knockout, suggesting a role for DRD5 in phosphoinositide hydrolysis [<xref ref-type="bibr" rid="CR31">31</xref>]. It has been reported that the mRNA of the <italic>drd5</italic> is expressed in SH-SY5Y cells [<xref ref-type="bibr" rid="CR32">32</xref>]. At this concern, the potential DRD5 role, via phosphoinositide hydrolysis and Ca2&#x02009;+&#x02009;mobilization, acting in parallel or independent of the PKA activation observed in our study, deserves to be evaluated.</p><p id="Par31">On the other hand, the timing of CREB phosphorylation has behavioral implications. T<italic>ransient</italic> CREB phosphorylation has been reported in striatal neurons, where emotion and habit formation (decision-making) occur. In contrast, <italic>sustained</italic> CREB phosphorylation is recorded in limbic-related structures that process and regulate emotion, memory, and learning [<xref ref-type="bibr" rid="CR10">10</xref>]. Further research is needed to determine the IEGs, parallel or independent pathways phosphorylating to CREB, and the neurophysiological functions derived from <italic>transient</italic> CREB phosphorylation induced by dopamine D1-like receptor activation.</p></sec><sec id="Sec21"><title>Dopamine D1-like Receptor-induced Local Synthesis of Arc</title><p id="Par32">Arc participates in memory/learning formation through hippocampal long-term potentiation (LTP) and synaptic processes associated with dopamine D1-like receptor activation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. However, its regulation from transcription, translation, and function has yet to be fully understood. Our results showed that dopamine D1-like receptor stimulation induced two transient spikes of Arc protein, an early increase (0.25&#x000a0;h) and a late increase (6&#x000a0;h). At both times, the location of Arc was near the cell membrane, forming clusters. However, at 6&#x000a0;h, the Arc signal was co-located with the F-actin signal, suggesting that dopamine D1-like receptor stimulation induces Arc spikes in specific subcellular regions depending on time. The early transient peak of Arc has yet to be reported. Arc&#x02019;s mRNA is known to be coupled with a ribonucleoprotein complex and transported to specific subcellular sites, forming subcellular hubs of Arc mRNA, where it remains until a neuronal stimulus input promotes a rapid translation of the Arc mRNA/ribonucleoprotein complex [<xref ref-type="bibr" rid="CR8">8</xref>]&#x0200b;. It has been proposed that these events are modulated by a process known as nonsense-mediated RNA decay (NMD), whose purpose is to eliminate certain kinds of RNA and is mainly orchestrated by eukaryotic translation initiation factor 4AIII [<xref ref-type="bibr" rid="CR34">34</xref>]&#x0200b;. The Arc mRNA is a natural target of the 4AIII. In our study, the early transient peak of Arc may be related to a local translation of preexistent Arc mRNA, followed by a quick decay in protein level underlying the NMD process induced by dopamine D1-like receptor activation. The transient augment of Arc at 6&#x000a0;h could correspond to a second round of Arc translation depending on p-CREB<sup>S133</sup> induced by intracellular pathways associated with dopamine D1-like receptor activation. It was shown that tetrodotoxin induced a second cycle of Arc translation in specific subcellular hotspots, operated by a feedback mechanism, where new proteins of the first cycle restart a second process of Arc transcription [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par33">Nevertheless, this second cycle of Arc translation seems to depend on neuronal input; stimulation of muscarinic, cholinergic, and glutamate receptors induces gradual but sustained Arc protein augment [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. These data contrast with the fluctuant behavior shown in the present study for Arc in response to the activation of the dopamine D1-like receptor. The Arc decreasing after early and late peak takes neurophysiological relevance. In knock-in mice where the Arc ubiquitination sites were mutated, it was shown that the abnormal persistence of Arc protein level over time was associated with a failure in cognitive flexibility [<xref ref-type="bibr" rid="CR11">11</xref>]. In this context, our results suggest that the dopamine D1-like receptor induces a particular dynamic in Arc protein induction with a specific timing; however, the meaning of the temporal expression on neurophysiological functions remains to be evaluated.</p><p id="Par34">The late spike (6&#x000a0;h) of Arc protein, with subcellular colocalization with F-actin-rich regions, could be relevant to synaptic processes like LTP and Long-Term Depression (LTD). In response to stimulation with neurotransmitters, the dendritic spines undergo restructuring, involving morphological changes in actin cytoskeleton rearrangement [<xref ref-type="bibr" rid="CR38">38</xref>]. As a coadjutant factor to actin polymerization dynamics, Arc interacts with actin-binding proteins, indirectly contributing to the regulation of neurotransmitter receptors&#x02019; enrichment in the cell membrane [<xref ref-type="bibr" rid="CR7">7</xref>], which are necessary for LTP and LTD. The Arc protein induction, dependent on dopamine D1-like receptor activation, could be a relevant player for crosstalk between other neurotransmitter-induced synaptic events, which involve actin cytoskeleton remodeling in specific sites. Our study provides new insights into the role of dopamine D1-like receptors on Arc levels, the timing of expression, and their specific subcellular location to potentially participate in distinct neuronal function.</p></sec><sec id="Sec22"><title>BDNF Secretion by Dopamine D1-like Receptor Activation</title><p id="Par35">The BDNF structure undergoes sequential modifications throughout its maturation process, resulting in pre-pro-BDNF, pro-BDNF, and mature BDNF [<xref ref-type="bibr" rid="CR9">9</xref>]. Only mature BDNF is secreted from neuronal cells and acts at autocrine and paracrine levels via tropomyosin-related kinase B receptor (TrkB) [<xref ref-type="bibr" rid="CR39">39</xref>]. How dopamine D1-like receptor activity contributes to BDNF regulation has yet to be fully elucidate. To our knowledge, this is the first study showing how dopamine D1-like receptor stimulation induces the secretion of mature BDNF with time-dependent fluctuations. Our results showed that after dopamine D1-like receptor activation, the maximum increase of BDNF secretion was reached at 6&#x000a0;h, partly correlating with intracellular BDNF protein in rat brain tissue stimulated with dopamine through the dopamine D1-like receptor [<xref ref-type="bibr" rid="CR40">40</xref>]. This data suggests that the dopamine D1-like receptor activation regulates intracellular and secreted BDNF. The BDNF secretion decreased below the baseline at 24&#x000a0;h of dopamine D1-like receptor activation. The meaning and mechanism of late BDNF decreasing, dependent on dopamine D1-like receptor, has not been determined. It is known that the secreted BDNF bounds to the TrkB receptor, and the BDNF-TrkB complex is endocytosed via an endosomal pathway eliciting signaling events related to survival and synaptic and cognitive function [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Our results on BDNF levels at 24&#x000a0;h align with previous results suggesting that extracellular BDNF is internalized via BDNF-TrkB complex recycling in striatal neurons [<xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec23"><title>Regulation of Neurite Extension by the Dopamine D1-like Receptor</title><p id="Par36">Neurites are structures that are essential for establishing synaptic contact among neurons that are far from each other. In processes like neurodevelopment, neurites will become axonal or dendritic structures [<xref ref-type="bibr" rid="CR44">44</xref>], and DA regulates neuronal connectivity development via its receptors [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Our results suggest that the dopamine D1-like receptor is relevant in maintaining neurite extension of RA-treated SH-SY5Y since neurite retraction occurred when the dopamine D1-like receptor was blocked. Previously, it was demonstrated that dopamine D1-like receptor induces growth cone formation and arborization in rat striatum [<xref ref-type="bibr" rid="CR46">46</xref>]. Conversely, DA can also decrease the neurite length in rat cortical neurons [<xref ref-type="bibr" rid="CR45">45</xref>]. This paradox may depend on DA tonicity and availability in the synaptic cleft; the DA will activate the dopamine D1-like receptor or the D2-like receptor with contrasting effects, high and low doses of DA, respectively [<xref ref-type="bibr" rid="CR47">47</xref>]. There is contradictory evidence about the D2-like receptor expression and dopamine secretion after the differentiation process in SH-SY5Y cells [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. If the cells were producing and releasing dopamine and expressing D2-like receptors, dopamine would activate these receptors, inducing neurite retraction. However, in our study, the control SH-SY5Y cells RA-differentiated showed neurite extension (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>S). These results suggest that in case of occurring, the dopamine (if it is secreted) and D2 receptor activity do not affect the neurite extension. These results support that SCH-23390 induces neurite retraction by antagonizing the D1 receptor effects.</p><p id="Par37">In our study, since a dopamine D1-like receptor agonist was used (SKF-38393), a bimodal pattern typical of DA was avoided, allowing us to hypothesize a potential role specifically for the dopamine D1-like receptor on neuronal projections regulation, maybe through BDNF. The dopamine D1-like receptor antagonist inhibited the BDNF secretion concomitantly with neurite retraction. One of the roles of BDNF is to regulate neuronal morphology, like neurites, dendritic, and growth cone formation, during the neurodevelopment process [<xref ref-type="bibr" rid="CR9">9</xref>]. Previously, it was demonstrated that deleting BDNF expression in hippocampal neurons produces failure in dendrite development [<xref ref-type="bibr" rid="CR39">39</xref>]. In another study, the treatment with BDNF enhanced hippocampal neurons&#x02019; number and neurite length [<xref ref-type="bibr" rid="CR50">50</xref>]. Our results suggest that the dopamine D1-like receptor activation induces BDNF secretion, which is probably involved, at least partly, in neurite extension regulation.</p><p id="Par38">In conclusion, dopamine D1-like receptor stimulation transiently induces CREB activation, the Arc protein expression in a spatiotemporal dynamic manner, fluctuant changes in BDNF secretion depending on the time, and regulates the neurites extension (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). This study provides new insights into the role of the dopamine D1-like receptor on CREB, Arc, and BDNF, critical players for synaptic functions. The implication and relevance of the dopamine D1-like receptor for regulating distinct processes associated with cognitive functions remained for further studies.</p><p id="Par39">
<fig id="Fig7"><label>Fig. 7</label><caption><p>Schematical representation of dynamic changes by dopamine D1-like receptor activation on p-CREB <sup>S133</sup>, Arc, BDNF. PKA is activated once the dopamine D1-like receptor is stimulated, and CREB is phosphorylated (<italic>p-CREB</italic><sup><italic>S133</italic></sup>). Arc protein is increased at 15&#x000a0;min, suggesting preexistent mRNA translation; a second increase at 6 suggests a second cycle of transcription and translation. BDNF secretion fluctuates over time, suggesting that in addition to stimulation of secretion, at 24&#x000a0;h, the dopamine D1-like receptor would induce the BDNF endocytosis (scheme was created with <ext-link ext-link-type="uri" xlink:href="http://BioRender.com">BioRender.com</ext-link>)</p></caption><graphic xlink:href="11064_2024_4293_Fig7_HTML" id="d33e943"/></fig>
</p></sec></sec><sec id="Sec24" sec-type="supplementary-material"><title>Electronic Supplementary Material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="11064_2024_4293_MOESM1_ESM.pdf"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors thank Dr. Jaime H. G&#x000f3;mez Zamudio (Centro M&#x000e9;dico Nacional Siglo XXI, IMSS, M&#x000e9;xico City, M&#x000e9;xico), his suggestions on the manuscript), and Ms.C. Ivan J. Galvan Mendoza for his technical help (confocal microscopy unit of National Experimental Services Laboratories at Cinvestav -LaNSE-).</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>E.S. C-A. and O.B. R-M. contributed to the conceptualization and experimental design of the study and discussed data. The experimental development, data collection, and writing of the draft manuscript were performed by O.B. R-M., C.D. O-R. and J.R. P-V. contribute to data analysis, results discussion, and figure preparation. E.S. C-A. reviewed and edited the manuscript and acquired the project funding. All authors reviewed draft versions and read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was funded by the Mexican Council for Science and Technology (Conacyt-A1-S-32913) to ESC-A.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing Interests</title><p id="Par40">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Beaulieu J-M, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63 182 LP&#x02013; 217. 10.1124/pr.110.002642</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Daba Feyissa</surname><given-names>D</given-names></name><name><surname>Sialana</surname><given-names>FJ</given-names></name><name><surname>Keimpema</surname><given-names>E</given-names></name><etal/></person-group><article-title>Dopamine type 1- and 2-like signaling in the modulation of spatial reference learning and memory</article-title><source>Behav Brain Res</source><year>2019</year><volume>362</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/J.BBR.2019.01.028</pub-id><pub-id pub-id-type="pmid">30659847</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Daba Feyissa D, Sialana FJ, Keimpema E et al (2019) Dopamine type 1- and 2-like signaling in the modulation of spatial reference learning and memory. Behav Brain Res 362:173&#x02013;180. 10.1016/J.BBR.2019.01.028<pub-id pub-id-type="pmid">30659847</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Granado</surname><given-names>N</given-names></name><name><surname>Ortiz</surname><given-names>O</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>LM</given-names></name><etal/></person-group><article-title>D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the Hippocampus</article-title><source>Cereb Cortex</source><year>2008</year><volume>18</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhm026</pub-id><pub-id pub-id-type="pmid">17395606</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Granado N, Ortiz O, Su&#x000e1;rez LM et al (2008) D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the Hippocampus. Cereb Cortex 18:1&#x02013;12. 10.1093/cercor/bhm026<pub-id pub-id-type="pmid">17395606</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Jones-Tabah</surname><given-names>J</given-names></name><name><surname>Mohammad</surname><given-names>H</given-names></name><name><surname>Paulus</surname><given-names>EG</given-names></name><etal/></person-group><article-title>The signaling and pharmacology of the dopamine D1 receptor</article-title><source>Front Cell Neurosci</source><year>2022</year><volume>15</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.3389/fncel.2021.806618</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Jones-Tabah J, Mohammad H, Paulus EG et al (2022) The signaling and pharmacology of the dopamine D1 receptor. Front Cell Neurosci 15:1&#x02013;28. 10.3389/fncel.2021.806618</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Steven</surname><given-names>A</given-names></name><name><surname>Friedrich</surname><given-names>M</given-names></name><name><surname>Jank</surname><given-names>P</given-names></name><etal/></person-group><article-title>What turns CREB on? And off? And why does it matter?</article-title><source>Cell Mol Life Sci</source><year>2020</year><volume>77</volume><fpage>4049</fpage><lpage>4067</lpage><pub-id pub-id-type="doi">10.1007/s00018-020-03525-8</pub-id><pub-id pub-id-type="pmid">32347317</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Steven A, Friedrich M, Jank P et al (2020) What turns CREB on? And off? And why does it matter? Cell Mol Life Sci 77:4049&#x02013;4067. 10.1007/s00018-020-03525-8<pub-id pub-id-type="pmid">32347317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Mart&#x000ed;nez</surname><given-names>S</given-names></name></person-group><article-title>A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis</article-title><source>Front Mol Neurosci</source><year>2015</year><volume>8</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3389/fnmol.2015.00046</pub-id><pub-id pub-id-type="pmid">25674046</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Ortega-Mart&#x000ed;nez S (2015) A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis. Front Mol Neurosci 8:1&#x02013;12. 10.3389/fnmol.2015.00046<pub-id pub-id-type="pmid">25674046</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolaienko</surname><given-names>O</given-names></name><name><surname>Patil</surname><given-names>S</given-names></name><name><surname>Eriksen</surname><given-names>MS</given-names></name><name><surname>Bramham</surname><given-names>CR</given-names></name></person-group><article-title>Arc protein: a flexible hub for synaptic plasticity and cognition</article-title><source>Semin Cell Dev Biol</source><year>2018</year><volume>77</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/J.SEMCDB.2017.09.006</pub-id><pub-id pub-id-type="pmid">28890419</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Nikolaienko O, Patil S, Eriksen MS, Bramham CR (2018) Arc protein: a flexible hub for synaptic plasticity and cognition. Semin Cell Dev Biol 77:33&#x02013;42. 10.1016/J.SEMCDB.2017.09.006<pub-id pub-id-type="pmid">28890419</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Bramham</surname><given-names>CR</given-names></name><name><surname>Alme</surname><given-names>MN</given-names></name><name><surname>Bittins</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Arc of synaptic memory</article-title><source>Exp Brain Res</source><year>2010</year><volume>200</volume><fpage>125</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1007/s00221-009-1959-2</pub-id><pub-id pub-id-type="pmid">19690847</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Bramham CR, Alme MN, Bittins M et al (2010) The Arc of synaptic memory. Exp Brain Res 200:125&#x02013;140. 10.1007/s00221-009-1959-2<pub-id pub-id-type="pmid">19690847</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Kowia&#x00144;ski</surname><given-names>P</given-names></name><name><surname>Lietzau</surname><given-names>G</given-names></name><name><surname>Czuba</surname><given-names>E</given-names></name><etal/></person-group><article-title>BDNF: a key factor with multipotent impact on Brain Signaling and synaptic plasticity</article-title><source>Cell Mol Neurobiol</source><year>2018</year><volume>38</volume><fpage>579</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1007/s10571-017-0510-4</pub-id><pub-id pub-id-type="pmid">28623429</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kowia&#x00144;ski P, Lietzau G, Czuba E et al (2018) BDNF: a key factor with multipotent impact on Brain Signaling and synaptic plasticity. Cell Mol Neurobiol 38:579&#x02013;593. 10.1007/s10571-017-0510-4<pub-id pub-id-type="pmid">28623429</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>FUC</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name></person-group><article-title>Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>4708</fpage><lpage>4713</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.8.4708</pub-id><pub-id pub-id-type="pmid">9539803</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Liu FUC, Graybiel AM (1998) Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia. Proc Natl Acad Sci U S A 95:4708&#x02013;4713. 10.1073/pnas.95.8.4708<pub-id pub-id-type="pmid">9539803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>MJ</given-names></name><name><surname>Collins</surname><given-names>DR</given-names></name><name><surname>Chery</surname><given-names>SL</given-names></name><etal/></person-group><article-title>The temporal dynamics of Arc expression regulate cognitive flexibility</article-title><source>Neuron</source><year>2018</year><volume>98</volume><fpage>1124</fpage><lpage>1132e7</lpage><pub-id pub-id-type="doi">10.1016/J.NEURON.2018.05.012</pub-id><pub-id pub-id-type="pmid">29861284</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Wall MJ, Collins DR, Chery SL et al (2018) The temporal dynamics of Arc expression regulate cognitive flexibility. Neuron 98:1124&#x02013;1132e7. 10.1016/J.NEURON.2018.05.012<pub-id pub-id-type="pmid">29861284</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>F</given-names></name><name><surname>Siller</surname><given-names>J</given-names></name><name><surname>Barral</surname><given-names>EM</given-names></name></person-group><article-title>Disorders of Protein Biogenesis and Stability</article-title><source>Protein Pept Lett</source><year>2011</year><volume>18</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.2174/092986611794475075</pub-id><pub-id pub-id-type="pmid">21121895</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Anderson F, Siller J, Barral EM J (2011) Disorders of Protein Biogenesis and Stability. Protein Pept Lett 18:110&#x02013;121. 10.2174/092986611794475075<pub-id pub-id-type="pmid">21121895</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Mahapatra</surname><given-names>KK</given-names></name><name><surname>Panigrahi</surname><given-names>DP</given-names></name><name><surname>Praharaj</surname><given-names>PP</given-names></name><etal/></person-group><article-title>Molecular interplay of autophagy and endocytosis in human health and diseases</article-title><source>Biol Rev</source><year>2019</year><volume>94</volume><fpage>1576</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1111/brv.12515</pub-id><pub-id pub-id-type="pmid">30989802</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Mahapatra KK, Panigrahi DP, Praharaj PP et al (2019) Molecular interplay of autophagy and endocytosis in human health and diseases. Biol Rev 94:1576&#x02013;1590. 10.1111/brv.12515<pub-id pub-id-type="pmid">30989802</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Encinas</surname><given-names>M</given-names></name><name><surname>Iglesias</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells</article-title><source>J Neurochem</source><year>2000</year><volume>75</volume><fpage>991</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0750991.x</pub-id><pub-id pub-id-type="pmid">10936180</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Encinas M, Iglesias M, Liu Y et al (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991&#x02013;1003. 10.1046/j.1471-4159.2000.0750991.x<pub-id pub-id-type="pmid">10936180</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Chin-Chan</surname><given-names>M</given-names></name><name><surname>Segovia</surname><given-names>J</given-names></name><name><surname>Quintanar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mercury reduces the enzymatic activity of neprilysin in differentiated SH-SY5Y cells</article-title><source>Toxicol Sci</source><year>2015</year><volume>145</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfv037</pub-id><pub-id pub-id-type="pmid">25673500</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Chin-Chan M, Segovia J, Quintanar L et al (2015) Mercury reduces the enzymatic activity of neprilysin in differentiated SH-SY5Y cells. Toxicol Sci 145:128&#x02013;137. 10.1093/toxsci/kfv037<pub-id pub-id-type="pmid">25673500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T</given-names></name></person-group><article-title>Rapid Colorimetric Assay for Cellular Growth and Survival: application to proliferation and cytotoxicity assays</article-title><source>J Lmmunological Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1039/c6ra17788c</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mosmann T (1983) Rapid Colorimetric Assay for Cellular Growth and Survival: application to proliferation and cytotoxicity assays. J Lmmunological Methods 65:55&#x02013;63. 10.1039/c6ra17788c</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>AJA</given-names></name><name><surname>Reyes</surname><given-names>VL</given-names></name><name><surname>Albores-Garc&#x000ed;a</surname><given-names>D</given-names></name><etal/></person-group><article-title>MeHg affects the activation of FAK, src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells</article-title><source>Toxicology</source><year>2018</year><volume>394</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2017.11.019</pub-id><pub-id pub-id-type="pmid">29197552</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Hern&#x000e1;ndez AJA, Reyes VL, Albores-Garc&#x000ed;a D et al (2018) MeHg affects the activation of FAK, src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells. Toxicology 394:35&#x02013;44. 10.1016/j.tox.2017.11.019<pub-id pub-id-type="pmid">29197552</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Monterrosas</surname><given-names>C</given-names></name><name><surname>D&#x000ed;az-Aragon</surname><given-names>R</given-names></name><name><surname>Leal-Orta</surname><given-names>E</given-names></name><etal/></person-group><article-title>Insulin induces an EMT-like process in mammary epithelial cells MCF10A</article-title><source>J Cell Biochem</source><year>2018</year><volume>119</volume><fpage>4061</fpage><lpage>4071</lpage><pub-id pub-id-type="doi">10.1002/jcb.26582</pub-id><pub-id pub-id-type="pmid">29236310</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Rodriguez-Monterrosas C, D&#x000ed;az-Aragon R, Leal-Orta E et al (2018) Insulin induces an EMT-like process in mammary epithelial cells MCF10A. J Cell Biochem 119:4061&#x02013;4071. 10.1002/jcb.26582<pub-id pub-id-type="pmid">29236310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes-V&#x000e1;zquez</surname><given-names>L</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>AJA</given-names></name><name><surname>Calder&#x000f3;n-Aranda</surname><given-names>ES</given-names></name></person-group><article-title>Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines</article-title><source>Toxicology</source><year>2020</year><volume>437</volume><fpage>152440</fpage><pub-id pub-id-type="doi">10.1016/j.tox.2020.152440</pub-id><pub-id pub-id-type="pmid">32197950</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Reyes-V&#x000e1;zquez L, Hern&#x000e1;ndez AJA, Calder&#x000f3;n-Aranda ES (2020) Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines. Toxicology 437:152440. 10.1016/j.tox.2020.152440<pub-id pub-id-type="pmid">32197950</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>Cognition: the ultimate brain function</article-title><source>Neuropsychopharmacology</source><year>2011</year><volume>36</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1038/npp.2010.171</pub-id><pub-id pub-id-type="pmid">21116247</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Robbins TW (2011) Cognition: the ultimate brain function. Neuropsychopharmacology 36:1&#x02013;2. 10.1038/npp.2010.171<pub-id pub-id-type="pmid">21116247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Teppola</surname><given-names>H</given-names></name><name><surname>Sarkanen</surname><given-names>JR</given-names></name><name><surname>Jalonen</surname><given-names>TO</given-names></name><name><surname>Linne</surname><given-names>ML</given-names></name></person-group><article-title>Morphological differentiation towards neuronal phenotype of SH-SY5Y Neuroblastoma cells by Estradiol, retinoic acid and cholesterol</article-title><source>Neurochem Res</source><year>2016</year><volume>41</volume><fpage>731</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1007/s11064-015-1743-6</pub-id><pub-id pub-id-type="pmid">26518675</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Teppola H, Sarkanen JR, Jalonen TO, Linne ML (2016) Morphological differentiation towards neuronal phenotype of SH-SY5Y Neuroblastoma cells by Estradiol, retinoic acid and cholesterol. Neurochem Res 41:731&#x02013;747. 10.1007/s11064-015-1743-6<pub-id pub-id-type="pmid">26518675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>HR</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Sen, Li</surname><given-names>GY</given-names></name></person-group><article-title>SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson&#x02019;s disease</article-title><source>Chin Med J (Engl)</source><year>2010</year><volume>123</volume><fpage>1086</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.3760/cma.j.issn.0366-6999.2010.08.021</pub-id><pub-id pub-id-type="pmid">20497720</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Xie HR, Hu L, Sen, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson&#x02019;s disease. Chin Med J (Engl) 123:1086&#x02013;1092. 10.3760/cma.j.issn.0366-6999.2010.08.021<pub-id pub-id-type="pmid">20497720</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B</given-names></name></person-group><article-title>BDNF and activity-dependent synaptic modulation</article-title><source>Learn Memory</source><year>2003</year><volume>10</volume><fpage>86</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1101/lm.54603</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Memory 10:86&#x02013;98. 10.1101/lm.54603</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaldun</surname><given-names>JC</given-names></name><name><surname>Sprecher</surname><given-names>SG</given-names></name></person-group><article-title>Initiated by CREB: Resolving Gene Regulatory Programs in Learning and Memory: switch in cofactors and transcription regulators between Memory Consolidation and Maintenance Network</article-title><source>BioEssays</source><year>2019</year><volume>41</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/bies.201900045</pub-id><pub-id pub-id-type="pmid">31545522</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kaldun JC, Sprecher SG (2019) Initiated by CREB: Resolving Gene Regulatory Programs in Learning and Memory: switch in cofactors and transcription regulators between Memory Consolidation and Maintenance Network. BioEssays 41:1&#x02013;14. 10.1002/bies.201900045<pub-id pub-id-type="pmid">31545522</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Kong</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Complex roles of cAMP&#x02013;PKA&#x02013;CREB signaling in cancer</article-title><source>Exp Hematol Oncol</source><year>2020</year><volume>9</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s40164-020-00191-1</pub-id><pub-id pub-id-type="pmid">31908904</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zhang H, Kong Q, Wang J et al (2020) Complex roles of cAMP&#x02013;PKA&#x02013;CREB signaling in cancer. Exp Hematol Oncol 9:1&#x02013;13. 10.1186/s40164-020-00191-1<pub-id pub-id-type="pmid">31908904</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Nijholt</surname><given-names>I</given-names></name><name><surname>Blank</surname><given-names>T</given-names></name><name><surname>Ahi</surname><given-names>J</given-names></name><name><surname>Spiess</surname><given-names>J</given-names></name></person-group><article-title>In vivo CREB phosphorylation mediated by dopamine and NMDA receptor activation in mouse hippocampus and caudate nucleus</article-title><source>Brain Res Gene Expr Patterns</source><year>2002</year><volume>1</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/s1567-133x(01)00020-5</pub-id><pub-id pub-id-type="pmid">15018806</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Nijholt I, Blank T, Ahi J, Spiess J (2002) In vivo CREB phosphorylation mediated by dopamine and NMDA receptor activation in mouse hippocampus and caudate nucleus. Brain Res Gene Expr Patterns 1:101&#x02013;106. 10.1016/s1567-133x(01)00020-5<pub-id pub-id-type="pmid">15018806</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimanpour</surname><given-names>E</given-names></name><name><surname>Bergado Acosta</surname><given-names>JR</given-names></name><name><surname>Landgraf</surname><given-names>P</given-names></name><etal/></person-group><article-title>Regulation of CREB phosphorylation in nucleus accumbens after relief conditioning</article-title><source>Cells</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.3390/cells10020238</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Soleimanpour E, Bergado Acosta JR, Landgraf P et al (2021) Regulation of CREB phosphorylation in nucleus accumbens after relief conditioning. Cells 10:1&#x02013;15. 10.3390/cells10020238</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>FC</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name></person-group><article-title>Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum</article-title><source>Neuron</source><year>1996</year><volume>17</volume><fpage>1133</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80245-7</pub-id><pub-id pub-id-type="pmid">8982161</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Liu FC, Graybiel AM (1996) Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron 17:1133&#x02013;1144. 10.1016/S0896-6273(00)80245-7<pub-id pub-id-type="pmid">8982161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>TX</given-names></name><name><surname>Kwok</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><article-title>Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein &#x003b2; in GH-stimulated c-fos expression</article-title><source>J Endocrinol</source><year>2008</year><volume>196</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1677/JOE-07-0169</pub-id><pub-id pub-id-type="pmid">18180320</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Cui TX, Kwok R, Schwartz J (2008) Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein &#x003b2; in GH-stimulated c-fos expression. J Endocrinol 196:89&#x02013;100. 10.1677/JOE-07-0169<pub-id pub-id-type="pmid">18180320</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosethorne</surname><given-names>EM</given-names></name><name><surname>Nahorski</surname><given-names>SR</given-names></name><name><surname>Challiss</surname><given-names>RAJ</given-names></name></person-group><article-title>Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells</article-title><source>Biochem Pharmacol</source><year>2008</year><volume>75</volume><fpage>942</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2007.10.015</pub-id><pub-id pub-id-type="pmid">18036509</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Rosethorne EM, Nahorski SR, Challiss RAJ (2008) Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells. Biochem Pharmacol 75:942&#x02013;955. 10.1016/j.bcp.2007.10.015<pub-id pub-id-type="pmid">18036509</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>A</given-names></name><name><surname>Tyeryar</surname><given-names>KR</given-names></name><name><surname>Vongtau</surname><given-names>HO</given-names></name><etal/></person-group><article-title>D 5 dopamine receptors are required for dopaminergic activation of phospholipase C</article-title><source>Mol Pharmacol</source><year>2009</year><volume>75</volume><fpage>447</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1124/mol.108.053017</pub-id><pub-id pub-id-type="pmid">19047479</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Sahu A, Tyeryar KR, Vongtau HO et al (2009) D 5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 75:447&#x02013;453. 10.1124/mol.108.053017<pub-id pub-id-type="pmid">19047479</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Zhou J, Peng C, Li Q Dopamine Homeostasis Imbalance and Dopamine, Receptors-Mediated et al (2022) AC/cAMP/PKA Pathway Activation are Involved in Aconitine-Induced Neurological Impairment in Zebrafish and SH-SY5Y Cells. Front Pharmacol 13:1&#x02013;21. 10.3389/fphar.2022.837810</mixed-citation></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>N</given-names></name><name><surname>Tainaka</surname><given-names>K</given-names></name><name><surname>Macpherson</surname><given-names>T</given-names></name><etal/></person-group><article-title>Neurotransmission through dopamine D1 receptors is required for aversive memory formation and Arc activation in the cerebral cortex</article-title><source>Neurosci Res</source><year>2020</year><volume>156</volume><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/J.NEURES.2020.04.006</pub-id><pub-id pub-id-type="pmid">32380131</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Saito N, Tainaka K, Macpherson T et al (2020) Neurotransmission through dopamine D1 receptors is required for aversive memory formation and Arc activation in the cerebral cortex. Neurosci Res 156:58&#x02013;65. 10.1016/J.NEURES.2020.04.006<pub-id pub-id-type="pmid">32380131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Stone</surname><given-names>ME</given-names></name><etal/></person-group><article-title>The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression</article-title><source>Cell</source><year>2007</year><volume>130</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/J.CELL.2007.05.028</pub-id><pub-id pub-id-type="pmid">17632064</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Giorgi C, Yeo GW, Stone ME et al (2007) The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression. Cell 130:179&#x02013;191. 10.1016/J.CELL.2007.05.028<pub-id pub-id-type="pmid">17632064</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Lituma</surname><given-names>PJ</given-names></name><name><surname>Castillo</surname><given-names>PE</given-names></name><name><surname>Singer</surname><given-names>RH</given-names></name></person-group><article-title>Maintenance of a short-lived protein required for long-term memory involves cycles of transcription and local translation</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>2051</fpage><lpage>2064</lpage><pub-id pub-id-type="doi">10.1016/J.NEURON.2023.04.005</pub-id><pub-id pub-id-type="pmid">37100055</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Das S, Lituma PJ, Castillo PE, Singer RH (2023) Maintenance of a short-lived protein required for long-term memory involves cycles of transcription and local translation. Neuron 111:2051&#x02013;2064.e6. 10.1016/J.NEURON.2023.04.005<pub-id pub-id-type="pmid">37100055</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Glutamate-induced rapid induction of Arc/Arg3.1 requires NMDA receptor-mediated phosphorylation of ERK and CREB</article-title><source>Neurosci Lett</source><year>2017</year><volume>661</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/J.NEULET.2017.09.024</pub-id><pub-id pub-id-type="pmid">28919534</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Chen T, Zhu J, Yang LK et al (2017) Glutamate-induced rapid induction of Arc/Arg3.1 requires NMDA receptor-mediated phosphorylation of ERK and CREB. Neurosci Lett 661:23&#x02013;28. 10.1016/J.NEULET.2017.09.024<pub-id pub-id-type="pmid">28919534</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Soul&#x000e9;</surname><given-names>J</given-names></name><name><surname>Alme</surname><given-names>M</given-names></name><name><surname>Myrum</surname><given-names>C</given-names></name><etal/></person-group><article-title>Balancing Arc Synthesis, mRNA decay, and proteasomal degradation: MAXIMAL PROTEIN EXPRESSION TRIGGERED BY RAPID EYE MOVEMENT SLEEP-LIKE BURSTS OF MUSCARINIC CHOLINERGIC RECEPTOR STIMULATION</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>22354</fpage><lpage>22366</lpage><pub-id pub-id-type="doi">10.1074/JBC.M112.376491</pub-id><pub-id pub-id-type="pmid">22584581</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Soul&#x000e9; J, Alme M, Myrum C et al (2012) Balancing Arc Synthesis, mRNA decay, and proteasomal degradation: MAXIMAL PROTEIN EXPRESSION TRIGGERED BY RAPID EYE MOVEMENT SLEEP-LIKE BURSTS OF MUSCARINIC CHOLINERGIC RECEPTOR STIMULATION. J Biol Chem 287:22354&#x02013;22366. 10.1074/JBC.M112.376491<pub-id pub-id-type="pmid">22584581</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Chazeau</surname><given-names>A</given-names></name><name><surname>Giannone</surname><given-names>G</given-names></name></person-group><article-title>Organization and dynamics of the actin cytoskeleton during dendritic spine morphological remodeling</article-title><source>Cell Mol Life Sci</source><year>2016</year><volume>73</volume><fpage>3053</fpage><lpage>3073</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2214-1</pub-id><pub-id pub-id-type="pmid">27105623</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Chazeau A, Giannone G (2016) Organization and dynamics of the actin cytoskeleton during dendritic spine morphological remodeling. Cell Mol Life Sci 73:3053&#x02013;3073. 10.1007/s00018-016-2214-1<pub-id pub-id-type="pmid">27105623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>She</surname><given-names>L</given-names></name><etal/></person-group><article-title>Autocrine Action of BDNF on Dendrite Development of Adult-born hippocampal neurons</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><fpage>8384</fpage><lpage>8393</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4682-14.2015</pub-id><pub-id pub-id-type="pmid">26041908</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Wang L, Chang X, She L et al (2015) Autocrine Action of BDNF on Dendrite Development of Adult-born hippocampal neurons. J Neurosci 35:8384&#x02013;8393. 10.1523/JNEUROSCI.4682-14.2015<pub-id pub-id-type="pmid">26041908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>SN</given-names></name><name><surname>Undieh</surname><given-names>AS</given-names></name></person-group><article-title>Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression</article-title><source>NeuroReport</source><year>2009</year><volume>20</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1097/WNR.0b013e32832a0a98</pub-id><pub-id pub-id-type="pmid">19295451</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Williams SN, Undieh AS (2009) Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression. NeuroReport 20:606&#x02013;610. 10.1097/WNR.0b013e32832a0a98<pub-id pub-id-type="pmid">19295451</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Moya-Alvarado G, Tiburcio-Felix R, Ib&#x000e1;&#x000f1;ez MR et al (2023) BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons. Elife 12. 10.7554/eLife.77455</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Piromalli Girado</surname><given-names>D</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Giachero</surname><given-names>M</given-names></name><etal/></person-group><article-title>Endocytosis is required for consolidation of pattern-separated memories in the perirhinal cortex</article-title><source>Front Syst Neurosci</source><year>2023</year><volume>17</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3389/fnsys.2023.1043664</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Piromalli Girado D, Miranda M, Giachero M et al (2023) Endocytosis is required for consolidation of pattern-separated memories in the perirhinal cortex. Front Syst Neurosci 17:1&#x02013;13. 10.3389/fnsys.2023.1043664</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Iwakura</surname><given-names>Y</given-names></name><name><surname>Nawa</surname><given-names>H</given-names></name><name><surname>Sora</surname><given-names>I</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name></person-group><article-title>Dopamine D1 receptor-induced signaling through TrkB receptors in Striatal Neurons</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>15799</fpage><lpage>15806</lpage><pub-id pub-id-type="doi">10.1074/JBC.M801553200</pub-id><pub-id pub-id-type="pmid">18381284</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Iwakura Y, Nawa H, Sora I, Chao MV (2008) Dopamine D1 receptor-induced signaling through TrkB receptors in Striatal Neurons. J Biol Chem 283:15799&#x02013;15806. 10.1074/JBC.M801553200<pub-id pub-id-type="pmid">18381284</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>G</given-names></name></person-group><article-title>Mechanisms underlying the initiation and Dynamics of neuronal Filopodia: from neurite formation to synaptogenesis</article-title><source>Int Rev Cell Mol Biol</source><year>2013</year><volume>301</volume><fpage>95</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-407704-1.00003-8</pub-id><pub-id pub-id-type="pmid">23317818</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Gallo G (2013) Mechanisms underlying the initiation and Dynamics of neuronal Filopodia: from neurite formation to synaptogenesis. Int Rev Cell Mol Biol 301:95&#x02013;156. 10.1016/B978-0-12-407704-1.00003-8<pub-id pub-id-type="pmid">23317818</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Lankford KL, DeMello FG, Klein WL (1988) D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system. Proceedings of the National Academy of Sciences 85:4567&#x02013;4571. 10.1073/pnas.85.12.4567-a</mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Reinoso BS, Undie AS, Levitt P (1996) Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res 43:439&#x02013;453. 10.1002/(SICI)1097-4547(19960215)43:4%3C439::AID-JNR5%3E3.0.CO;2-G</mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Baik J-H (2013) Dopamine signaling in reward-related behaviors. Front Neural Circuits 7</mixed-citation></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Mastroeni</surname><given-names>D</given-names></name><name><surname>Grover</surname><given-names>A</given-names></name><name><surname>Leonard</surname><given-names>B</given-names></name><etal/></person-group><article-title>Microglial responses to dopamine in a cell culture model of Parkinson&#x02019;s disease</article-title><source>Neurobiol Aging</source><year>2009</year><volume>30</volume><fpage>1805</fpage><lpage>1817</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.01.001</pub-id><pub-id pub-id-type="pmid">18325635</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Mastroeni D, Grover A, Leonard B et al (2009) Microglial responses to dopamine in a cell culture model of Parkinson&#x02019;s disease. Neurobiol Aging 30:1805&#x02013;1817. 10.1016/j.neurobiolaging.2008.01.001<pub-id pub-id-type="pmid">18325635</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Magalingam</surname><given-names>KB</given-names></name><name><surname>Radhakrishnan</surname><given-names>AK</given-names></name><name><surname>Somanath</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line</article-title><source>Mol Biol Rep</source><year>2020</year><volume>47</volume><fpage>8775</fpage><lpage>8788</lpage><pub-id pub-id-type="doi">10.1007/s11033-020-05925-2</pub-id><pub-id pub-id-type="pmid">33098048</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Magalingam KB, Radhakrishnan AK, Somanath SD et al (2020) Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line. Mol Biol Rep 47:8775&#x02013;8788. 10.1007/s11033-020-05925-2<pub-id pub-id-type="pmid">33098048</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>K</given-names></name><name><surname>Shintani</surname><given-names>N</given-names></name><name><surname>Hayata-Takano</surname><given-names>A</given-names></name><etal/></person-group><article-title>PACAP enhances Axon Outgrowth in cultured hippocampal neurons to a comparable extent as BDNF</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0120526</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0120526</pub-id><pub-id pub-id-type="pmid">25807538</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Ogata K, Shintani N, Hayata-Takano A et al (2015) PACAP enhances Axon Outgrowth in cultured hippocampal neurons to a comparable extent as BDNF. PLoS ONE 10:e0120526. 10.1371/journal.pone.0120526<pub-id pub-id-type="pmid">25807538</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>